Strategy

With the grant of a patent, Futura is hoping to take its Eroxon product to China, a country with a large population of ED sufferers, the firm claims.

Covestus Holdings will pay £4.3m to acquire UK-based Venture Life’s oral care brands Ultradex and Dentyl.

France, Spain and Belgium among countries where Cooper Consumer Health has launched NRT brand Nicotinell on behalf of Dr Reddy’s.

Reckitt's leadership discussed the company's growth strategy for emerging markets at a recent meeting for analysts.

A round-up of the latest people moves: Stada names general counsel; Nestlé announces departures; CMA elects board members.

“In the coming years, growth will depend on whether brands can combine trust, personalization, and proof of evidence into one coherent prevention experience,” argue Simon Kucher's Clemens Oberhammer and Christian Rebholz in this exclusive interview.

A round up of the latest people moves in Europe: ANEFP names president; Pharma Deutschland makes board changes; Salus shakes up management.

Opella is honoring its commitment to maintaining production volumes, investment levels, and jobs at its French plants by spending €40m to upgrade two sites in the country.

UK consumer healthcare industry association, PAGB, suggests improvements that could help accelerate Rx-to-OTC switch in the country.

Negative growth in global OTC market sales volume means that “as an industry, we're not doing good enough,” argues Opella’s Asia Pacific, Middle East and Africa (AMEA) head, Carol-Ann Stewart, in this exclusive feature interview.

UK development firm Futura Medical is set to raise £2.75m to keep the company operational and provide cash for its R&D plans.

A round-up of the latest European people news: Haleon elects board chair; Bayer names group CFO; Boots adds customer & marketing director.

“It’s not good enough just to provide products anymore, we need to create a service and a holistic approach to products,” argued Bayer Consumer Health's Northern Europe general manager, Mike Knowland, speaking at a recent panel event in the UK Parliament.

Bayer expects Consumer Health sales for the full year to advance by 1% at best due to increasingly challenging conditions in its two largest markets.

EllaOne manufacturer Perrigo tells HBW Insight that Community Pharmacy England's decision to offer free emergency contraception is "the right move for women" but also "makes pharmacy training and sex education more important than ever."

Cipla has paid Tata Industries around $12.5m for Inzpera Healthsciences to grow its consumer health portfolio.

Karo will take on responsibility for the marketing, distribution and sales of Moberg’s topical onychomycosis treatment, MOB-15, under the Lamisil brand in 19 European countries.

A round-up of the latest European people moves: Stada names new heads for Germany and UK; Orifarm makes board appointment; MHRA fills new chief medical and scientific officer role.

Enzymatica says it is taking "longer than we expected" to sign up partners to launch its ColdZyme innovation across North America and Asia.

Haleon delivers organic sales growth of 3.4% in Q3 despite ongoing challenges in the US related to consumer spending.